Latest Close
$4.76
News
AARD
Aardvark Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to AARD.
1y Change
-$11.50 (-70.73%)
Market Cap
$104,171,872.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
GlobeNewswire • Oct 8, 2026
Read articleAardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Oct 2, 2026
Read articleAardvark Therapeutics' ARD-101 Path Forward May Be Challenging, RBC Says
MT Newswires • Sep 24, 2026
Read articleAardvark Therapeutics Insider Sold Shares Worth $394,957, According to a Recent SEC Filing
MT Newswires • Sep 14, 2026
Read articleAardvark Therapeutics Inc (AARD) (Q2 2026) Earnings Call Highlights: Board Re-Elected, Auditor ...
GuruFocus.com • Aug 17, 2026
Read article